Journal
LANCET NEUROLOGY
Volume 4, Issue 10, Pages 653-661Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(05)70194-0
Keywords
-
Categories
Funding
- FIC NIH HHS [TW05562] Funding Source: Medline
- NIAID NIH HHS [U01 AI35894, P01 AI51976] Funding Source: Medline
- PHS HHS [01107] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
Neurocysticercosis, the infection of the human brain by the larvae of Taenia solium, is a major cause of acquired epilepsy in most low-income countries. Cases of neurocysticercosis are becoming more common in high-income countries because of increased migration and travel. Diagnosis by neuroimaging and serological assessment has greatly improved over the past decade, and the natural progression of the disease and response to antiparasitic drugs is now much better understood. Neurocysticercosis is potentially eradicable, and control interventions are underway to eliminate this infection. Meanwhile, updated information on diagnosis and management of neurocysticercosis is required, especially for clinicians who are unfamiliar with its wide array of clinical presentations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available